EBIT at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's EBIT?
- Ligand Pharmaceuticals (LGND) reported EBIT of $17.37M in Q1 2026.
- How has Ligand Pharmaceuticals's EBIT changed year-over-year?
- Ligand Pharmaceuticals's EBIT increased by 148.0% year-over-year, from -$36.22M to $17.37M.
- What is the long-term trend for Ligand Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's EBIT has grown at a -20.7% compound annual growth rate (CAGR), from $103.85M to $41M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.